Abstract:Background: Regional lymph node invasion and metastasis may happen early during the progres-sion of gastric cancer. The lymphadenectomy is still the key method to treat lymph nodemetastasis. In the recent years, scientists have found some growth factors and receptors that can promote angiogenesis which also play an important role in adjusting the formation of the new lymph vessel, and lymphangiogenesis may play a key role in the process of lymph node metastasis. Objectives: This study aims to explore the correlation between the expression of vascular endothelial growth factor-C (VEGF-C), vascular endothelial growth factor receptor 3 (VEGFR-3) and lymph node me-tastasis (LNM), and its impact on prognosis of patients with gastric cancer. Methods: The samples were collected from gastric cancer database of Sichuan Provincial People’s Hospital from 2005 to 2007, which were registered and followed up. The samples were divided into two groups according to situation whether there is lymph node metastasis, which is lymph node metastasis N(+) and without lymph node metastasis N(﹣). The expression of VEGF-C, VEGFR-3 and CD34 were measured by immuno histochemistry staining with monoclonal antibody (anti-VEGF-C, anti-VEGFR-3, and anti-CD34). Kaplan-meier, logistic and Cox regression was performed to explore their impact on the prognosis of patients with gastric cancer. Results: In total 186 cases were collected, 96 cases in N(+) group and 90 cases in N(﹣) group. The percentage of VEGF-C expression is 54.83% (102/186) in all groups, 73.9% (71/96) in N(+) group, and 34.44% (31/90) in N(﹣) group (p = 0.001). The percentage of VEGFR-3 expression is 33.33% (62/186) in all groups, 44.78% (43/96) in N(+) group, and 21.11% (19/90) in N(﹣) group (p = 0.001). There are no statistical differences in microvessel density (MVD) between N(﹣) and N(+) group. The average lymphatic vessel density (LVD) was significant different between N(+) and N(﹣) group (26.23 ± 8.2 and 18.46 ± 7.4, t = ﹣2.427, p = 0.016). The five-year overall survival rate of N(+) group is 31% and the N(﹣) group is 66%; there are statistical differences between the two groups (Log rank = 27.15, p = 0.001). The five-year overall survival rates of VEGF-C positive group and VEGF-C negative group are 36% and 59%, with the statistical differences (Log rank = 27.15, p = 0.001). And the five-year overall survival rates of VEGFR-3 positive group and VEGFR-3 negative group are 31% and 43%, also with the statistical differences (Log rank = 5.241, p = 0.041). Conclusions: The expressions of VEGF-C, VEGFR-3 in cell plasma of gastric cancer tissue not only correlate with lymphatic vessel density and lymph node metastasis (LNM), but also are important factors which impact prognosis of gastric cancer patients.

Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Carcinoma of Ampulla of Vater.

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

Clinical Significance of VEGF and MVD Expression in Esophageal Carcinomas

Vascular Endothelial Growth Factor and Microvascular Density in Esophageal and Gastric Carcinomas

Expression and Significance of Vascular Endothelial Growth Factor and Microvessel Density in Pancreatic Carcinoma

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis

Expression and Significance of Ang-2,VEGF and MVD in Gastric Carcinoma

[Expression of Vascular Endothelial Growth Factors (VEGF)-A, -C and -D and Their Prognostic Significance and Relationship with Angio- and Lymphangiogenesis in Gastric Cancer].

Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma.

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Gastric Cancer Tissues

Clinicopathological Prognostic Factors and Chemotherapeutic Outcome for Two Histopathological Types of Ampulla of Vater Adenocarcinoma

[The Relationship of Vascular Endothelial Growth Factor and Angiogenesis to the Progression of Gastric Carcinoma].

Relationship Between the Expression of Vascular Endothelial Growth Factor, Fms-Like Tyrosine Kinase-1 and Biological Behavior in Gastric Carcinoma

Clinical significances and relationship between vascular endothelial growth factor expression and microvessel density in gastric carcinoma

Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma

The expression of vascular endothelial cell growth factor and the microvessel density and their relationship with pathological types and clinical stages of gastric carcinoma

Expression and Its Significance of VEGF in Gallbladder Carcinomas

[Tumor Angiogenesis in Node-Negative Breast Carcinoma].

Expression Of Vegf And Correlation Of Mvd And Tidc In Periampullary Adencocarcinoma Tissues

[Vascular Endothelial Growth Factor Expression and Microvessel Density in Stage I-II Non-Small Cell Lung Cancer and Their Prognostic Significances].

The Expression of VEGF-C and It’s Receptor VEGFR-3 Correlates with Lymph Node Metastasis in Gastric Cancer